Stonepine Capital Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Stonepine Capital Management, LLC

$123 Billion
Q3 2025

A detailed history of Stonepine Capital Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 195,000 shares of VNDA stock, worth $848,249. This represents 0.79% of its overall portfolio holdings.

Number of Shares

195,000

Previous 250,000 22.0%

Holding current value

$848,249

Previous $1.18 Billion 17.54%

% of portfolio

0.79%

Previous 1.16%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$4.19 - $5.1 $230,450 - $280,500	-55,000 Reduced 22.0%	195,000 $973 Million
Q2 2025 Aug 13, 2025	BUY	$3.92 - $4.82 $842,219 - $1.04 Million	214,852 Added 611.28%	250,000 $1.18 Billion
Q1 2025 May 14, 2025	BUY	$4.31 - $5.13 $43,737 - $52,059	10,148 Added 40.59%	35,148 $161 Million
Q4 2024 Feb 13, 2025	BUY	$4.41 - $5.46 $110,250 - $136,500	25,000 New	25,000 $120 Million
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $2.05 Million - $3.14 Million	477,903 New	477,903 $2.06 Billion

Q3 2019 Nov 13, 2019	SELL	$12.27 - $15.79 $16.5 Million - $21.2 Million	-1,341,943 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$13.37 - $18.85 $1.09 Million - $1.54 Million	81,655 Added 6.48%	1,341,943 $18.9 Million
Q1 2019 May 14, 2019	BUY	$17.59 - $31.05 $18.3 Million - $32.3 Million	1,039,440 Added 470.66%	1,260,288 $23.2 Million
Q4 2018 Feb 13, 2019	SELL	$18.97 - $31.47 $1.97 Million - $3.27 Million	-103,752 Reduced 31.96%	220,848 $5.77 Million
Q3 2018 Nov 13, 2018	SELL	$18.25 - $23.0 $5.03 Million - $6.33 Million	-275,400 Reduced 45.9%	324,600 $7.45 Million
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $5.36 Million - $7.36 Million	-384,584 Reduced 39.06%	600,000 $11.4 Million
Q1 2018 May 14, 2018	BUY	$14.05 - $20.2 $1.4 Million - $2.01 Million	99,584 Added 11.25%	984,584 $16.6 Million
Q4 2017 Feb 13, 2018	BUY	$12.85 - $18.1 $7.52 Million - $10.6 Million	585,000 Added 195.0%	885,000 $13.5 Million
Q3 2017 Nov 13, 2017	SELL	$15.4 - $18.85 $5.93 Million - $7.26 Million	-385,086 Reduced 56.21%	300,000 $5.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	685,086	685,086 $11.2 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.5M

Call Options Held

159K

Put Options Held

229K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $246M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Account

Stonepine Capital Management, LLC Vanda Pharmaceuticals Inc. Transaction History